Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Replication defective viral vectors for infecting human cells

Replication defective viral vectors for infecting human cells

US Patent 6133029 · Granted Oct 17, 2000

Estimated economic value: $175,808,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant vectors comprising 2A peptide2022
Retroviral vector having immune-stimulating activity2022
Retroviral vector having immune-stimulating activity2022
Formulations of 5-fluorocytosine and uses thereof2021
Formulations of 5-fluorocytosine and uses thereof2021
Retroviral vector with mini-promoter cassette2021
Retroviral vector with mini-promoter cassette2021
Producer cells for replication competent retroviral vectors2021
Formulations of 5-fluorocytosine and uses thereof2019
Formulations of 5-fluorocytosine and uses thereof2019
Recombinant vectors2019
Recombinant vectors2019